Hair Testing May Offer Insights into Asthma-Related Complications in Pregnancy
By LabMedica International staff writers Posted on 28 Jul 2015 |
In an oral poster presentation of the “Endocrinology in Preventive and Chronic Care” session at AACC 2015 (July 26-30; Atlanta, GA, USA), researchers presented and discussed results of a study suggesting that simple, noninvasive testing of hair samples may offer new insights into the relationship between asthma, levels of the stress-hormone cortisol, and related complications in pregnancy.
Currently, researchers would require frequent blood or saliva samples to measure and track cortisol levels during pregnancy. In addition to being time consuming, these measurements are difficult to interpret as they reflect only one point in time. Cortisol fluctuates during the day. Hair, on the other hand, stores cortisol levels over a long period of time. Each segment of about 1 cm offers a look back at what the levels were during a particular month.
To investigate whether hair samples could be used to assess effects of the chronic inflammatory lung disease asthma on cortisol levels during pregnancy, a research team led by Gideon Koren, MD, University of Toronto (Canada), and Bruce Carleton, PharmD, University of British Columbia (Canada), tested for cortisol in hair samples from 93 pregnant women, of whom 62 had asthma and 31 did not. About half the women with asthma were being treated with inhaled corticosteroids.
“For both the control and the asthma groups we could see a rise in cortisol over the course of the pregnancy and then a decline during the postpartum period,” said study coauthor Laura Smy, PhD student, University of Toronto (Canada). This finding supports the use of hair samples as a tool for assessing cortisol levels during pregnancy.
The study also made an unanticipated finding, however. “For the individuals with asthma, whether or not they were using inhaled corticosteroids, their response to the cortisol increase was dampened,” said Smy, “They had significantly lower hair cortisol levels during both their 2nd and 3rd trimesters than the women in the control group.” The finding suggests that levels of cortisol tend to be lower among pregnant women with asthma. This may be due to “adrenal fatigue”—prolonged exposure to high cortisol levels that eventually causes the adrenal glands to significantly reduce their output of the hormone.
While research has established that high cortisol levels are associated with an elevated risk of miscarriage and premature birth, some increase during pregnancy may have a beneficial effect. Indeed, research suggests that higher cortisol levels late in pregnancy are needed for fetal organs to mature, especially the lungs, thyroid, and digestive tract. The new study offers a simpler tool that could help scientists unravel this complicated relationship and determine if and how cortisol is linked to pregnancy outcomes.
“We hope hair samples will help establish the role that changes in cortisol levels throughout pregnancy have on the health of women and their children,” said Smy. Future research will be needed to both confirm this study’s findings and to determine the role that changes in cortisol during pregnancy may have on pregnancy outcomes and fetal wellbeing.
Related Links:
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo
Currently, researchers would require frequent blood or saliva samples to measure and track cortisol levels during pregnancy. In addition to being time consuming, these measurements are difficult to interpret as they reflect only one point in time. Cortisol fluctuates during the day. Hair, on the other hand, stores cortisol levels over a long period of time. Each segment of about 1 cm offers a look back at what the levels were during a particular month.
To investigate whether hair samples could be used to assess effects of the chronic inflammatory lung disease asthma on cortisol levels during pregnancy, a research team led by Gideon Koren, MD, University of Toronto (Canada), and Bruce Carleton, PharmD, University of British Columbia (Canada), tested for cortisol in hair samples from 93 pregnant women, of whom 62 had asthma and 31 did not. About half the women with asthma were being treated with inhaled corticosteroids.
“For both the control and the asthma groups we could see a rise in cortisol over the course of the pregnancy and then a decline during the postpartum period,” said study coauthor Laura Smy, PhD student, University of Toronto (Canada). This finding supports the use of hair samples as a tool for assessing cortisol levels during pregnancy.
The study also made an unanticipated finding, however. “For the individuals with asthma, whether or not they were using inhaled corticosteroids, their response to the cortisol increase was dampened,” said Smy, “They had significantly lower hair cortisol levels during both their 2nd and 3rd trimesters than the women in the control group.” The finding suggests that levels of cortisol tend to be lower among pregnant women with asthma. This may be due to “adrenal fatigue”—prolonged exposure to high cortisol levels that eventually causes the adrenal glands to significantly reduce their output of the hormone.
While research has established that high cortisol levels are associated with an elevated risk of miscarriage and premature birth, some increase during pregnancy may have a beneficial effect. Indeed, research suggests that higher cortisol levels late in pregnancy are needed for fetal organs to mature, especially the lungs, thyroid, and digestive tract. The new study offers a simpler tool that could help scientists unravel this complicated relationship and determine if and how cortisol is linked to pregnancy outcomes.
“We hope hair samples will help establish the role that changes in cortisol levels throughout pregnancy have on the health of women and their children,” said Smy. Future research will be needed to both confirm this study’s findings and to determine the role that changes in cortisol during pregnancy may have on pregnancy outcomes and fetal wellbeing.
Related Links:
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo
Latest AACC 2015 News
- Automated Molecular Diagnostics System Presented at AACC 2015
- Portable Molecular Diagnostics System Unveiled At 2015 AACC
- Expanded Steroid Control Launched at the 2015 AACC Annual Meeting
- Innovative New Technology to Provide Plastic-Exterior Components with Glass Interior, Presented at AACC 2015
- Eco-Friendly Immunoassay Reagents Featured at AACC 2015
- Low Cost Point-of-Care DNA Amplification Test for Chlamydia Infection Demonstrated at the 2015 AACC Annual Meeting
- Inexpensive Multipurpose Point-of-Care Analyzer Unveiled at 2015 AACC Annual Meeting
- State-of-the-Art Automated Laboratory Systems Highlighted at the 2015 AACC Annual Meeting
- Siemens Showcases Multiple New IVD Solutions at AACC 2015
- New HPLC Quadruples Clinical Throughput Capabilities, Displayed at AACC 2015
- Diagnostic Test that Measures Active Renin in Hypertension Displayed at the 2015 AACC Annual Meeting
- Two Newly Developed Tests May Better Diabetes Diagnosis and Monitoring
- CE Marking of Theranostic Monitoring Test Announced at 2015 AACC Annual Meeting
- Ebola Rapid Lateral Flow Test Previewed at the 2015 AACC Annual Meeting
- AACC: Better Quality and Patient-Friendliness Needed in Direct Testing
- Clinical Chemistry Instruments and Reagents Under Scrutiny at the 2015 AACC Annual Meeting
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more